Suppr超能文献

氯磺丙脲治疗后出现低钠血症和低血糖。病例报告并复习18例氯磺丙脲所致低钠血症的文献

[Hyponatremia and hypoglycemia after treatment with chlorpropamide. Case histories with review of the literature on 18 cases of chlorpropamide induced hyponatremia].

作者信息

Bründler H, Berger W

出版信息

Schweiz Med Wochenschr. 1978 Jul 8;108(27):1035-40.

PMID:663598
Abstract

A case of chlorpropamide-induced, symptomatic hyponatremia in a diabetic patient is reported. The hyponatremia was associated with loss of appetite, nausea, and vomiting. These symptoms caused reduced food intake which provoked severe hypoglycemia with disturbed consciousness. The hyponatremia developed when the chlorpropamide doses were increased from 400 to 600 mg/day. Withdrawal of chlorpropamide was followed by remission of hyponatremia. Chlorpropamide-induced hyponatremia is a rare complication and is due to an antidiuretic effect of chlorpropamide caused by increased secretion of adiuretin and potentiation of the effect of chlorpropamide caused by increased secretion of adiuretin and potentiation of the effect of adiuretin in the tubuli of the kidney. This case report and the analysis of 18 published cases in the literature show the following characteristics for chlorpropamide-induced hyponatremia: (1) Hyponatremia is a rare complication in the treatment of diabetics with chlorpropamide. The patients typically are female and over sixty. The dosage of chlorpropamide usually was 500 mg daily or even more. (2) Hyponatremia is often unrecognized for a long time because the symptoms are not specific. The characteristic symptoms include loss of appetite, nausea, vomiting, abdominal pain, confusional state and, rarely, convulsions and coma. Recovery occurs spontaneously after withdrawal of the drug. (3) The incidence of this type of hyponatremia is increased in cases of preexisting tendency to water retention such as heart failure and renal failure, and in cases of diuretic therapy. In the light of these findings, the authors believe that chlorpropamide is no longer a drug of choice in the treatment of diabetic women, especially in cases of preexisting tendency to water retention and in diuretic therapy. In such cases, a sulfonylurea without antidiuretic effect is to be preferred.

摘要

报告了1例糖尿病患者因氯磺丙脲诱发的症状性低钠血症。低钠血症伴有食欲不振、恶心和呕吐。这些症状导致食物摄入量减少,进而引发严重低血糖并伴有意识障碍。当氯磺丙脲剂量从每日400mg增加到600mg时出现了低钠血症。停用氯磺丙脲后低钠血症缓解。氯磺丙脲诱发的低钠血症是一种罕见的并发症,是由于氯磺丙脲的抗利尿作用,这是由抗利尿激素分泌增加以及抗利尿激素分泌增加对氯磺丙脲作用的增强和在肾小管中抗利尿激素作用的增强所引起的。本病例报告以及对文献中18例已发表病例的分析显示了氯磺丙脲诱发低钠血症的以下特征:(1)低钠血症是氯磺丙脲治疗糖尿病患者时的罕见并发症。患者通常为女性且年龄超过60岁。氯磺丙脲的剂量通常为每日500mg或更高。(2)低钠血症往往长时间未被识别,因为症状不具有特异性。特征性症状包括食欲不振、恶心、呕吐、腹痛、意识模糊状态,很少有抽搐和昏迷。停药后可自发恢复。(3)在已有水潴留倾向的情况下,如心力衰竭和肾衰竭,以及在利尿治疗的情况下,这种类型低钠血症的发生率会增加。鉴于这些发现,作者认为氯磺丙脲不再是治疗糖尿病女性的首选药物,尤其是在已有水潴留倾向和利尿治疗的情况下。在这种情况下,应优先选择无抗利尿作用的磺脲类药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验